Lupus Around the World
- 1 September 2007
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 16 (9) , 755-763
- https://doi.org/10.1177/0961203307079943
Abstract
This study demonstrates demographic, clinical and laboratory characteristics with special reference to infections in Saudi patients with SLE. One-hundred and ninety-nine patients with SLE treated at Riyadh Armed Forces Hospital, Saudi Arabia over a period of 15 years (1990—2005) were retrospectively reviewed. There were 162 females and 37 males (4.4 : 1) with an average age of 35 years at onset of disease. Duration of diseases ranged from one to 23 years with a mean of 7.23 years. Some of the clinical characteristics of SLE patients observed were nephritis (53.7%), fever (53.26%), neuropsychological disorder (36.18%), malar/butterfly rash (27.6%), pulmonary disorder (22.6%), photosensitivity (21.6%), cardiac involvement (21.1%) and oral ulcers (19.09%). Infection was the major complication with 58.79% of SLE patient having suffered from various infections. A total of 22 species of pathogens including gram positive and gram negative bacteria, viruses and fungi were isolated from 117 SLE patients. Single to multiple episode of infection with various pathogens were recorded however, majority of patients harboured one or two species of pathogens. Bacterial infection was predominant (78.6%) followed by viral (28.2%) and fungal (28.2%) infections. Forty-four percent of SLE patients were found to be infected with organisms classified as opportunistic. The high incidence of infections in SLE patients may be attributed to the multiple intrinsic and extrinsic risk factors including deficiency of complement (C3 and C4), disease activity, renal impairment, use of glucocorticoid and cytotoxic drugs. It is concluded that more judicious use of corticosteroids and other immunosuppressive agents will be critical to limit the infections in SLE and a high alert and close monitoring of patients will ensure optimal patient outcome, both in terms of morbidity and mortality. Lupus (2007) 16, 755—763.Keywords
This publication has 85 references indexed in Scilit:
- Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2001
- Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2The Journal of Experimental Medicine, 2000
- Regulation of B Lymphocyte Responses to Foreign and Self-Antigens by the CD19/CD21 ComplexAnnual Review of Immunology, 2000
- Complement and immune complexesResearch in Immunology, 1996
- Risk factors for infection in Malaysian patients with systemic lupus erythematosusQJM: An International Journal of Medicine, 1996
- Clinical, serologic, and immunogenetic studies in childhood‐onset systemic lupus erythematosusArthritis & Rheumatism, 1993
- Complement deficiency and diseaseImmunology Today, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Survival in systemic lupus erythematosus. a multivariate analysis of demographic factorsArthritis & Rheumatism, 1987
- The Role of Complement and Its Receptor in the Elimination of Immune ComplexesNew England Journal of Medicine, 1986